Ligand Pharmaceuticals Overview

  • Founded
  • 1987
Founded
  • Status
  • Public
  • Employees
  • 155
Employees
  • Stock Symbol
  • LGND
Stock Symbol
  • Investments
  • 26
  • Share Price
  • $145.23
  • (As of Monday Closing)

Ligand Pharmaceuticals General Information

Description

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Contact Information

Website
www.ligand.com
Formerly Known As
Progenx
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Therapeutic Devices
Stock Exchange
NAS
Primary Office
  • 3911 Sorrento Valley Boulevard
  • Suite 110
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ligand Pharmaceuticals Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$145.23 $145.89 $78.26 - $219.75 $2.42B 16.7M 323K $2.42

Ligand Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 2,577,792 1,264,139 1,324,536 2,588,243
Revenue 208,408 186,419 120,282 251,453
EBITDA 78,393 36,770 847,685 224,307
Net Income 39,252 (2,985) 629,302 143,321
Total Assets 1,295,121 1,362,285 1,494,915 1,260,803
Total Debt 359,923 456,414 650,184 636,297
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ligand Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ligand Pharmaceuticals‘s full profile, request access.

Request a free trial

Ligand Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creat
Drug Discovery
San Diego, CA
155 As of 2020
000.00
000000 - 000 000.00

000000 0

bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000 000000000
Taipei, Taiwan
000 As of 0000
000.00
000000000 000.00

00000000

henderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cup
0000000000000
Cambridge, MA
000 As of 0000
00000
0.000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ligand Pharmaceuticals Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Taiwan Liposome Formerly VC-backed Taipei, Taiwan 000 000.00 000000000 000.00
000000000 000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
000000 00000000000 Formerly VC-backed Columbia, MD 000 000.00 000000&0 000.00
000000000000 00000 Corporate Backed or Acquired Trevose, PA 00 00000 00000000000 00000
00000000 000000 Formerly VC-backed Hellerup, Denmark 000 00000 000000 - 000 00000
You’re viewing 5 of 13 competitors. Get the full list »

Ligand Pharmaceuticals Executive Team (19)

Name Title Board Seat Contact Info
John Higgins Chief Executive Officer & Board Member
Matthew Foehr Chief Operating Officer, Operations & President
Matthew Korenberg Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Todd Pettingill Senior Director, Corporate Development
Charles Berkman JD General Counsel, Legal & Secretary, Administration
You’re viewing 5 of 19 executive team members. Get the full list »

Ligand Pharmaceuticals Board Members (10)

Name Representing Role Since
Jason Aryeh Self Board Member 000 0000
John Higgins Ligand Pharmaceuticals Chief Executive Officer & Board Member 000 0000
John Kozarich Ph.D Self Chairman & Board Member 000 0000
John LaMattina Ph.D Self Board Member 000 0000
Sarah Boyce Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Ligand Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ligand Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ligand Pharmaceuticals‘s full profile, request access.

Request a free trial

Ligand Pharmaceuticals Investments & Acquisitions (26)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 08-Dec-2020 00000 00000 00 00.00 Drug Delivery 000 000 00.0
000000 01-Oct-2020 000000000000000000 00000 Biotechnology 0000 0000000
000000 00000000000 10-Sep-2020 000000000000000000 00.00 Biotechnology 0000 0000000
000000 00000000000 08-Sep-2020 000000000000000000 000.00 Drug Discovery 0000 0000000
Palvella Therapeutics 28-May-2020 Later Stage VC 0000 Biotechnology
You’re viewing 5 of 26 investments and acquisitions. Get the full list »

Ligand Pharmaceuticals Subsidiaries (6)

Company Name Industry Location Founded
Taurus Biosciences Biotechnology San Diego, CA 2018
000000 00000000000 Drug Discovery Menlo Park, CA 0000
000000 Biotechnology San Diego, CA 0000
0000000 0000000000 Discovery Tools (Healthcare) Emeryville, CA 0000
0000 00 Pharmaceuticals Palo Alto, CA 0000
You’re viewing 5 of 6 subsidiaries. Get the full list »

Ligand Pharmaceuticals Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 10-Oct-2018 000000000000000000 0000 Completed
  • 000000 00000000000
000000 00000000000 29-Apr-2015 000 0000 Completed
  • 000000 00000000000
000000 00000000000 23-May-2014 00000000000 0000 00.00 Completed
  • 000000 00000000000
0-000000 000000000 07-Oct-1999 0000 00000 0000 Completed
  • 7 buyers
Marathon Pharmaceuticals 01-Feb-1999 Merger/Acquisition 000 Completed
To view Ligand Pharmaceuticals’s complete exits history, request access »